My Journey Into Biotech Investing

Hey everyone, Dylan Jovine here with Behind the Markets. Happy Friday the 13th! As we get into the Halloween season, I wanted to take a moment to reflect on something near and dear to my heart-Biotech Insider. It’s been quite a journey, and this year marks our seventh anniversary. I started Biotech Insider after facing my own health challenges, which sparked a deep interest in biotech stocks and the revolutionary work happening in medicine.
Biotech is not for the faint of heart, and while we’ve had some big wins-up 400% in some cases-we’ve also faced challenges, especially during the “biotech winters” when it seemed like nothing was happening. But our average return since 2018 has been over 50%, and I believe that’s due to our passion and curiosity in understanding the science behind these breakthroughs.
Thank you to all of our subscribers, especially those who have been with us from the beginning. I’m grateful for your support and excited for the future as we continue this journey together. Wishing you all a wonderful weekend!
✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼
/ @behindthemarkets
✅ VISIT OUR WEBSITE 👇🏼👇🏼
behindthemarke...